Target intelligence / Profile preview

Cytochrome P450 enzymes involved in estradiol metabolism (CYP (estradiol metabolism))

Target
CYP (estradiol metabolism)
Molecular classification
Enzyme, Heme-thiolate protein, Monooxygenase, Cytochrome P450 family
01

Overview

Cytochrome P450 (CYP) enzymes involved in estradiol metabolism are a group of heme-containing monooxygenases responsible for the oxidative biotransformation of estrogens. The primary enzymes include CYP1A1, CYP1A2, CYP1B1, and CYP3A4, which catalyze the hydroxylation of estradiol at the C-2, C-4, and C-16 positions (Tsuchiya et al., 2005). In the liver, CYP1A2 and CYP3A4 are the dominant isoforms for 2-hydroxylation, while CYP1B1 is highly expressed in extrahepatic tissues like the breast and uterus, where it specifically catalyzes 4-hydroxylation (McFadyen et al., 2004). The balance between these metabolic pathways is critical, as 4-hydroxyestradiol can undergo redox cycling to produce reactive oxygen species and DNA-damaging quinones, contributing to carcinogenesis (Zhu & Conney, 1998). Conversely, 2-hydroxy metabolites are generally considered less active or protective. These enzymes are significant pharmacological targets and sites of drug-drug interactions, as many clinical agents can induce or inhibit their activity, thereby altering systemic and local estrogen levels (Lee et al., 2003).

Other names
Estrogen-metabolizing Cytochrome P450sEstrogen hydroxylasesCYP1A1/1A2/1B1/3A4Catechol estrogen-forming enzymes
02

Mechanism of action

Oxidative metabolism (hydroxylation) of estradiol to catechol estrogens (2-hydroxyestradiol and 4-hydroxyestradiol) and 16alpha-hydroxy metabolites.

03

Biological functions

Steroid metabolismHormone homeostasisHydroxylationXenobiotic metabolismMetabolic clearance
04

Disease associations

Breast cancerEndometrial cancerOvarian cancerHormone-dependent cancersEndocrine disorders
05

Safety considerations

Drug-drug interactions (DDIs) due to induction or inhibitionGenotoxicity of 4-hydroxyestradiol metabolitesHormonal imbalance leading to endocrine disruptionIncreased risk of hormone-dependent carcinogenesis
06

Interacting drugs

Tamoxifen

9 more in the full profile.

07

Biomarkers

2-hydroxyestrone/16alpha-hydroxyestrone ratioCYP1B1 expression levelsCYP1A1 genetic polymorphisms (e.g., rs4646903)Urinary estrogen metabolite profiles

Beyond the preview

Go deeper on Cytochrome P450 enzymes involved in estradiol metabolism (CYP (estradiol metabolism)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cytochrome P450 enzymes involved in estradiol metabolism (CYP (estradiol metabolism)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call